INVARIANT LLC

Lobbying for EGENESIS INC. · Gene editing platform for the development of transplantable organs.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · Massachusetts · House · Senate · $110,000.00 income · posted Apr 21, 2025

Lobbying activity 1

Health Issues

Educate lawmakers and policymakers on xenotransplantation.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.